|
Powered by Cell Signaling Technology |
Site Information |
---|
TrGSPNRsLPsPGVL SwissProt Entrez-Gene |
Blast this site against: NCBI SwissProt PDB |
Site Group ID: 451446 |
In vivo Characterization | |
---|---|
Methods used to characterize site in vivo: | |
Disease tissue studied: | |
Relevant cell line - cell type - tissue: |
Upstream Regulation | |
---|---|
Putative in vivo kinases: | |
Kinases, in vitro: | |
Treatments: |
Downstream Regulation | |
---|---|
Effects of modification on ATF-4: | |
Effects of modification on biological processes: |
Disease / Diagnostics Relevance | |
---|---|
Relevant diseases: |
References | |
---|---|
Fan CF, et al. (2014) Expression of a phosphorylated form of ATF4 in lung and non-small cell lung cancer tissues. Tumour Biol 35, 765-71
23975372 Curated Info |
|
Mertins P, et al. (2013) Integrated proteomic analysis of post-translational modifications by serial enrichment. Nat Methods 10, 634-7
23749302 Curated Info |
|
Fan CF, Mao XY, Wang EH (2012) Elevated p-CREB-2 (ser 245) expression is potentially associated with carcinogenesis and development of breast carcinoma. Mol Med Report 5, 357-62
22052162 Curated Info |
|
Yang X, et al. (2004) ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell 117, 387-98
15109498 Curated Info |